Dr. Reddy’s Laboratories is currently trading at Rs. 5551.05, up by 74.55 points or 1.36% from its previous closing of Rs. 5476.50 on the BSE.
The scrip opened at Rs. 5535.00 and has touched a high and low of Rs. 5613.85 and Rs. 5425.00 respectively. So far 36005 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs. 5 has touched a 52 week high of Rs. 5613.85 on 27-Jul-2023 and a 52 week low of Rs. 3996.10 on 19-Sep-2022.
Last one week high and low of the scrip stood at Rs. 5613.85 and Rs. 5270.00 respectively. The current market cap of the company is Rs. 92722.80 crore.
The promoters holding in the company stood at 26.69%, while Institutions and Non-Institutions held 48.98% and 11.78% respectively.
Dr. Reddy’s Laboratories has reported results for first quarter ended June 30, 2023 (Q1FY24).
The company has reported over 3- fold jump in net profit at Rs 1639.40 crore for the quarter ended June 30, 2023 as compared to Rs 499.50 crore for the same quarter in the previous year. Total income of the company increased by 40.58% at Rs 5670.90 crore for Q1FY24 as compared Rs 4034.00 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 18.17% rise in its net profit at Rs 1405.00 crore for the quarter under review as compared to Rs 1189.00 crore for the same quarter in the previous year. Total income of the company increased by 13.88% at Rs 6931.90 crore for Q1FY24 as compared Rs 6086.80 crore for the corresponding quarter previous year.